Skip to search formSkip to main contentSkip to account menu

Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder

Known as: Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorder 
This entity represents a spectrum of lymphoproliferative disorders characterized by CD30 (Ki-1)-positive cutaneous T-cell infiltrates. The two ends… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Several peripheral T-cell lymphomas (PTCL) express the tumour necrosis factor (TNF) receptor CD30, conferring cell survival and… 
2016
2016
CD30-positive cutaneous lymphoproliferative disorders, a group of T-cell neoplasms, including lymphomatoid papulosis (LyP) and… 
Review
2012
Review
2012
An association between classical Hodgkin lymphoma (cHL) and mycosis fungoides (MF) or lymphomatoid papulosis has been reported in… 
2012
2012
BACKGROUND The serum level of soluble CD30 (sCD30) is known to be increased with several lymphomas and to correlate with… 
2012
2012
CD30, a 120 kDa type I surface glycoprotein, is a member of the tumor necrosis factor receptor (TNFR) superfamily, which is… 
2009
2009
We presented a rare case of primary cutaneous Epstein–Barr virus‐positive, CD30‐positive anasplastic large cell lymphoma in a 64… 
Review
2005
Review
2005
We reported a case of intravascular T-cell lymphoma (T-IVL) with anaplastic large cell morphology, the hemophagocytic syndrome… 
Review
1994
Review
1994
Although PTCL in children, as in adults, has a spectrum of clinical, morphologic, cytogenetic and immunologic features, there are… 
1994
1994
BACKGROUND We retrospectively assessed the long-term prognostic importance of primary CD30 antigen expression and of anaplastic… 
1993
1993
Die Behandlung maligner Non-Hodgkin-Lymphome richtet sich nach der histologischen Klassifikation und dem klinischen Stadium. In…